AR and Familial prostate cancer: In a prostate cancer model using transgenic mice, the onset of prostatic tumorigenesis as well as tumor growth was significantly potentiated by introduction of an AR point mutation (AR T877A) into the prostate and genetic screening of mice identified Wnt-5a as an activator [119].